UroGen Pharma Ltd - Bathi mangsa ngarep URGN

URGN (UroGen Pharma Ltd) - tandha merek perusahaan

UroGen Pharma Ltd. (URGN) ensures uninterrupted access to therapy thanks to streamlined oncology drug supply chains. The company's earnings forecast history reflects market expectation trends, with the indicator settling at 0.12. The issuer is implementing a local chemotherapy platform to minimize surgical interventions, while the unique RTGel guarantees pricing power due to inelastic demand for non-surgical tumor treatment.

URGN: Bathi mangsa ngarep urogen.com 03.03.2026 - 18.11.2026

UroGen - rincian analitis lan metrik utama (URGN)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:urogen.com
Barang utama UroGen Pharma Ltd

This metric aggregates market expectations for net income, measuring the business's ability to generate cash flow after all operating and tax expenses. The analytical earnings forecast reflects the commercialization pace of the innovative gel from UroGen Pharma (URGN), where the upward trend confirms the effective monetization of patent protection and the drug's transition into an industry standard for urology.

Pesaing utama

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|BCAX - Bathi mangsa ngarep|PSNL: Bathi mangsa ngarep|ERAS - Proyeksi bathi mangsa ngarep|Delcath (DCTH) - Bathi sing dikarepake|YmAbs - Penghasilan resik sing dikarepake|AURA (Aura Biosciences Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Candel Therapeutics CADL|Proyeksi bathi mangsa ngarep ARAY|SLS - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ACTU (Actuate Therapeutics Inc)|Prakiraan bathi perusahaan Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Protara Therapeutics, Inc.|FATE: Proyeksi bathi mangsa ngarep|WHWK - Prakiraan bathi perusahaan|Bathi sing dikarepake TScan Therapeutics, Inc.|Champions Oncology - Bathi forward|Proyeksi bathi mangsa ngarep XBIT|Prakiraan bathi perusahaan CEL-SCI Corp|Bathi sing dikarepake OS Therapies OSTX|Penghasilan resik sing dikarepake RADX|artivabio.com - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Bathi mangsa ngarep|TPST: Bathi resik mangsa ngarep|XLO (Xilio) - Proyeksi bathi mangsa ngarep|renovarobio.com (RENB) - Prakiraan bathi perusahaan|Bathi sing dikarepake Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep OKUR (OnKure Therapeutics, Inc.)|Penghasilan resik sing dikarepake GDTC|Curis Inc. - Proyeksi bathi mangsa ngarep|APLM (apollomicsinc.com) - Prakiraan bathi resik|THAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Advanced Biomed Inc. (ADVB)|Bathi sing dikarepake Genprex, Inc|Proyeksi bathi mangsa ngarep calidibio.com|Bathi sing dikarepake Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep SLRX (salariuspharma.com)|Purple Biotech - Bathi sing dikarepake|AONC: Bathi mangsa ngarep|BGNE - Proyeksi bathi mangsa ngarep|CKPT (checkpointtx.com) - Bathi mangsa ngarep|Bathi resik sing dikarepake elevationoncology.com (ELEV)|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake